Upgrade to SI Premium - Free Trial

WAVE Life Sciences (WVE)

3.37 -0.05 (1.46%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026 October 20, 2026 8:30 AM - StreetInsider Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026 October 19, 2026 8:30 AM - StreetInsider William Blair Starts WAVE Life Sciences (WVE) at Outperform October 16, 2026 3:11 AM - StreetInsider Form ARS Wave Life Sciences, Inc. For: Dec 31 October 14, 2026 5:17 PM - SEC Filing Form DEF 14A Wave Life Sciences, Inc. For: Nov 12 October 14, 2026 5:15 PM - SEC Filing UBS Starts WAVE Life Sciences (WVE) at Buy October 14, 2026 4:45 PM - StreetInsider Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare Conference October 13, 2026 8:30 AM - StreetInsider Form 4 Wave Life Sciences, Inc. For: Oct 05 Filed by: RA Capital Healthcare Fund LP October 7, 2026 9:07 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Oct 05 Filed by: TAKANASHI KEN October 7, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Oct 05 Filed by: CORRIGAN MARK October 7, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Oct 05 Filed by: Tan Aik Na October 7, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Oct 05 Filed by: Verdine Gregory L. October 7, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Oct 05 Filed by: Rawcliffe Adrian October 7, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Oct 05 Filed by: Wagner Heidi L October 7, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Oct 05 Filed by: HENRY CHRISTIAN O October 7, 2026 9:00 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE) October 2, 2026 6:58 AM - StreetInsider Wave Life Sciences gets FDA backing for WVE-006 registrational trial October 1, 2026 7:30 AM - StreetInsider Wave Life Sciences Announces FDA Feedback Supports Registrational Pathway for WVE-006 (RNA Editing) in AATD October 1, 2026 7:30 AM - StreetInsider GSK selects Wave Life Sciences siRNA candidate, triggering $12M payment September 30, 2026 7:31 AM - StreetInsider Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development September 30, 2026 7:30 AM - StreetInsider Wave Life Sciences starts Phase 2a combo trial of WVE-007 with tirzepatide September 23, 2026 7:30 AM - StreetInsider Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity September 23, 2026 7:30 AM - StreetInsider JPMorgan Resumes WAVE Life Sciences (WVE) at Neutral September 23, 2026 2:50 AM - StreetInsider Wave Life Sciences names Monika Vnuk as chief business officer September 22, 2026 7:30 AM - StreetInsider Wave Life Sciences Announces Appointment of Dr. Monika Vnuk as Chief Business Officer September 22, 2026 7:30 AM - StreetInsider Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference September 3, 2026 4:05 PM - StreetInsider Form 4 Wave Life Sciences, Inc. For: Aug 11 Filed by: Wagner Heidi L August 13, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Aug 11 Filed by: TAKANASHI KEN August 13, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Aug 11 Filed by: Tan Aik Na August 13, 2026 9:00 PM - SEC Filing Form 4 Wave Life Sciences, Inc. For: Aug 12 Filed by: Rawcliffe Adrian August 13, 2026 9:00 PM - SEC Filing Form SCHEDULE 13D/A Wave Life Sciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P. August 11, 2026 4:40 PM - SEC Filing Form 144 Wave Life Sciences, Inc. Filed by: Wagner Heidi L August 11, 2026 4:31 PM - SEC Filing Wave Life Sciences moves its parent company from Singapore to Delaware August 10, 2026 8:30 AM - StreetInsider Wave Life Sciences Announces Completion of Redomiciliation to Delaware August 10, 2026 8:30 AM - StreetInsider Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form POS AM Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form 15-12G Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form POSASR Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:04 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form S-8 POS Wave Life Sciences, Inc. August 10, 2026 6:03 AM - SEC Filing Form 8-K12B Wave Life Sciences, Inc. For: Aug 07 August 7, 2026 4:52 PM - SEC Filing Wave Life Sciences to complete Delaware redomiciliation on Aug. 7 August 5, 2026 4:06 PM - StreetInsider Wave Life Sciences Announces Expected Completion Date for Redomiciliation to Delaware August 5, 2026 4:06 PM - Globe NewsWire Wave Life Sciences to Present at Upcoming Investor Conferences August 4, 2026 8:30 AM - StreetInsider WAVE Life Sciences (WVE) PT Lowered to $23 at Mizuho August 4, 2026 6:39 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE) August 3, 2026 6:58 AM - StreetInsider WAVE Life Sciences (WVE) PT Lowered to $22 at B.Riley July 31, 2026 8:16 AM - StreetInsider Form 10-Q Wave Life Sciences Ltd. For: Jun 30 July 30, 2026 7:51 AM - SEC Filing WAVE Life Sciences (WVE) Misses Q2 EPS by 4c July 30, 2026 7:45 AM - StreetInsider Form 8-K Wave Life Sciences Ltd. For: Jul 30 July 30, 2026 7:38 AM - SEC Filing Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update July 30, 2026 7:30 AM - StreetInsider Full Article List